And roundups of analyst notes show that 2 are rating the stock a buy while 1 rate CL a strong buy. It shifted up 6.36% in contrast to its 200 day moving average of $82.17. 0 analysts assign “Sell” rating for the stock. In the past 52 weeks, the equity’s price traded between $59.95 and $ 75.38. Equities research analysts anticipate that Colgate-Palmolive will post $2.79 earnings per share for the current year.
Advertisement
The company holds a leadership position in the global toothpaste market with its worldwide market share of around 43.8%.
For the next year first quarter, analysts predicted EPS estimates trend of $0.76, which would leave an impact on the stock performance in coming months.
07/12/2016 – Colgate-Palmolive Company had its “neutral” rating reiterated by analysts at Goldman Sachs.
Colgate-Palmolive (NYSE:CL) is among those stocks, on which investors can bet safely without having any real risk of losing on their investments. Colgate-Palmolive Company has a 52-week low of 61.37 and a 52-week high of 75.38. A year ago, the payout was $0.39, which indicates a difference of 5.6338%.
In Colgate-Palmolive Company (NYSE:CL)’s most recent quarter, EPS moved to $0.70 from $0.63 in prior quarter and revenues reached at $3,845.00M versus $3,762.00M.
Moreover, CL’s strong management also led it to generate gross profit margins, operating profit margins and net income growth in the latest quarter, compared with the same period of a year ago.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 15th. Stockholders of record on Monday, October 24th will be given a $0.39 dividend.
To accommodate long-term intention, the firm has diverse dividend or yield record, CL has Dividend Yield of 2.20% and experts calculate Return on Investment of 25.20%. The ex-dividend date of this dividend is Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio is now 100.65%. Its Chief Technology Officer Verduin Patricia sold 3,674 company shares for $275000.55, in a transaction on 2016-08-15. Following the transaction, the director now directly owns 26,474 shares of the company’s stock, valued at $1,966,488.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The shares were sold at an average price of $74.69, for a total value of $5,889,231.81. The disclosure for this sale can be found here. The firm has a market cap of $63.17 billion, a P/E ratio of 45.63 and a beta of 0.59.
Insiders own 0% percent of the stock. The company’s net profit margin has achieved the current level of 12.7% and possesses 68.9% gross margin. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition.
Advertisement
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. Citigroup has a Street high PT of $88 on Colgate-Palmolive. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia.
